Table 5 correlation between diaphragmatic excursion difference with effusion-related and other functional-related indices
From: Assessment of diaphragmatic role in dyspneic patients with pleural effusion
Improvement (excursion difference) | Test value | P value | |||
|---|---|---|---|---|---|
No | Yes | ||||
N = 11 | N = 19 | ||||
BMI | Mean± SD | 29.34 ± 7.79 | 27.05 ± 6.51 | 0.864 | 0.395 |
Range | 13.84 – 39.79 | 16.9–40 | |||
Exudates/transudate | Exudates | 11 (100.0%) | 18 (94.7%) | 0.599 | 0.439 |
Transudate | 0 (0.0%) | 1 (5.3%) | |||
Effusion side | Right | 4 (36.4%) | 9 (47.4%) | 0.344 | 0.558 |
Left | 7 (63.6%) | 10 (52.6%) | |||
Cause of effusion | Adeno | 4 (36.4%) | 8 (42.1%) | 6.623 | 0.469 |
Met. Adeno | 2 (18.2%) | 5 (26.3%) | |||
TB pl. effusion | 1 (9.1%) | 2 (10.5%) | |||
Para p. effusion | 1 (9.1%) | 2 (10.5%) | |||
Mesothelioma | 2 (18.2%) | 0 (0.0%) | |||
NHL | 1 (9.1%) | 0 (0.0%) | |||
Empyema | 0 (0.0%) | 1 (5.3%) | |||
HF | 0 (0.0%) | 1 (5.3%) | |||
Effusion duration (months) | Median (IQR) | 4 (1 – 6) | 2 (1–3) | −1.567 | 0.117 |
Range | 0.33 – 9 | 0.75–7 | |||
Amount drained | Mean±SD | 1427.27 ± 405.19 | 1168.42 ± 266.78 | 2.115 | 0.043 |
6MWD | Median (IQR) | 150 (100 – 290) | 200 (100–300) | −0.389 | 0.697 |
Range | 80 – 360 | 60–450 | |||
FVC (L) | Mean±SD | 1.65 ± 0.54 | 1.74 ± 0.47 | −0.480 | 0.635 |
Range | 0.93 – 2.64 | 0.94–2.52 | |||
FVC (%) | Mean±SD | 42.59 ± 11.12 | 46.84 ± 10.80 | −1.028 | 0.313 |
Range | 25 – 68 | 31.6–63 | |||
FEV1 (L) | Mean±SD | 1.41 ± 0.51 | 1.43 ± 0.43 | −0.126 | 0.901 |
Range | 0.85 – 2.42 | 0.84–2.09 | |||
FEV1 (%) | Mean±SD | 45.70 ± 12.71 | 45.99 ± 12.24 | −0.063 | 0.950 |
Range | 27 – 75.62 | 29.22–67.2 | |||